characteristics.text: SAMN11918206
characteristics.characteristic: External Id
characteristics.text: Baylor College of Medicine
characteristics.characteristic: INSDC center name
characteristics.text: 2022-10-27T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-10-27T01:19:18.483Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS4856684
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS4856684
characteristics.characteristic: SRA accession
characteristics.text: Resistant
characteristics.characteristic: anti-her2 resistance
characteristics.text: SKBR3
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0001236
characteristics.characteristic: cell model
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: human breast cancer cells
characteristics.characteristic: source_name
characteristics.text: SKBR3-LTR
characteristics.characteristic: title
characteristics.text: Lapatinib plus trastuzumab, long-term
characteristics.characteristic: treatment